Welcome to our dedicated page for Infusystem Hld news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on Infusystem Hld stock.
InfuSystem Holdings, Inc. (NYSE American: INFU) regularly issues news and press releases that are of interest to investors, analysts and others following the health care services and durable medical equipment space. The company describes itself as a national health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers, with operations organized into Patient Services and Device Solutions platforms.
News items about InfuSystem often include quarterly and annual financial results, where the company discusses net revenues, segment performance for Patient Services and Device Solutions, gross margin trends, cash flow, and Adjusted EBITDA. These releases typically highlight how oncology, pain management and wound therapy within Patient Services, as well as rentals, pump and consumable sales, and biomedical services within Device Solutions, have contributed to overall results.
Another common category of news involves guidance and outlook. InfuSystem has used press releases to provide or reaffirm guidance ranges for net revenue growth and Adjusted EBITDA margin for upcoming fiscal years, and to explain how factors such as revenue mix, information technology projects, and capital expenditures may affect margins and cash flow.
The company also issues announcements about leadership changes and corporate governance, such as the CEO transition disclosed in April 2025, and about participation in investor conferences hosted by firms like ROTH and Craig-Hallum. These items often note that management will host one-on-one or small group meetings with investors.
In addition, InfuSystem uses news releases to communicate regulatory and policy developments that affect its business. For example, an 8-K dated December 10, 2025 references a press release announcing that the Centers for Medicare and Medicaid Services added two electronic infusion pumps used in the company’s Pain Management services business to the list of qualifying products for separate payment under the NOPAIN Act.
Visitors to the INFU news page can review this stream of financial updates, guidance, leadership announcements, conference participation notices and regulatory disclosures to understand how the company describes its performance and strategic priorities over time.
InfuSystem Holdings reported record revenues of $26 million for Q2 2020, marking a 32% year-over-year increase. The net income surged to $4.1 million, up from $0.4 million last year, reflecting a tenfold growth. Adjusted EBITDA also rose significantly, reaching $8.5 million, an 87% increase. The company reestablished its full-year guidance, projecting revenues between $94 million and $97 million and adjusted EBITDA between $23 million and $26 million. However, management cautioned that the elevated demand driven by COVID-19 may not persist.
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its second-quarter 2020 financial results on August 13, 2020, prior to market opening. A conference call for investors is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the financial results. The call can be accessed by dialing (833) 366-1127 or via live webcast on the Company's website. InfuSystem is a national provider of infusion pumps and durable medical equipment services, serving hospitals and clinics across the U.S. and Canada.
InfuSystem Holdings, Inc. (NYSE American: INFU) announced its inclusion in the FTSE Russell 2000® Index, effective after market close on June 26, 2020. This milestone is expected to enhance the company's visibility among institutional investors, as stated by CEO Richard DiIorio. InfuSystem, a provider of infusion pumps and related support services, aims to build on its operational success and expand into new therapies. The Russell 2000® Index is a key benchmark for small-cap companies, covering a significant portion of the market.
InfuSystem, a health care service provider, will present at the Lytham Partners Virtual Investor Conference on May 20, 2020, at 1:00 p.m. ET. CEO Richard DiIorio and CFO Barry Steele will speak at the event. A webcast of the presentation can be accessed on the company’s website, with a replay available afterward. Management will also hold virtual one-on-one meetings on May 21, 2020. InfuSystem offers infusion pumps and durable medical equipment support services and operates multiple Centers of Excellence across North America. Its stock is traded under the symbol INFU.
InfuSystem Holdings reported first quarter 2020 net revenues of $21.6 million, an increase of 18% year-over-year, driven by growth in both segments. Gross profit rose 22% to $12.7 million, with a gross margin of 58.8%. The company achieved an adjusted EBITDA of $4.1 million, marking a 30% increase. The net loss improved to $(0.4 million) or $(0.02) per diluted share. Despite challenges from COVID-19, oncology billings reached record levels. However, pain management revenues declined due to elective surgery delays, impacting overall performance.